STOCK TITAN

CARISMA THERAPEUTICS INC (CARM) Net Income by Year

CARM

CARISMA THERAPEUTICS INC reported a net loss of $60.5M in fiscal year 2024. This represents an increase of 30.4% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to $8.0M in net income. The table below carries 13 fiscal years, from 2012 to 2024, and the quarters CARISMA THERAPEUTICS INC has filed alongside them.

FY2024 annual
Net Income -$60.5M
YoY +30.4%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CARM Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Net Income$8.0M-$60.5M+30.4%-$86.9M-41.9%-$61.2M-18122.0%-$336K+98.5%-$22.4M+79.2%-$107.5M-219.1%-$33.7M-16.1%-$29.0M-1635.1%$1.9M+105.7%-$33.5M+2.1%-$34.2M-89.5%-$18.0M+8.3%-$19.7M

TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

CARM Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-K
Net Income$44.7M+452.0%-$9.8M+12.4%-$9.3M+51.2%-$17.6M+15.9%-$12.7M+40.7%-$11.2M+43.8%-$19.0M+23.0%-$21.0M-25.2%-$21.4M-16.8%-$19.9M-33.9%-$24.6M-117.8%-$16.7M

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More CARISMA THERAPEUTICS INC financials

Frequently Asked Questions

What was CARISMA THERAPEUTICS INC's net income in fiscal year 2024?

CARISMA THERAPEUTICS INC reported a net loss of $60.5M in fiscal year 2024.

How fast is CARISMA THERAPEUTICS INC's net income growing?

CARISMA THERAPEUTICS INC (CARM) net income rose by 30.4% year over year, from -$86.9M to -$60.5M in fiscal year 2024.

What is CARISMA THERAPEUTICS INC's net income over the last twelve months?

CARISMA THERAPEUTICS INC (CARM) reported $8.0M in net income over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

Across the 13 fiscal years this page covers, CARISMA THERAPEUTICS INC (CARM) net income went from -$19.7M in fiscal year 2012 to -$60.5M in fiscal year 2024.

CARISMA THERAPEUTICS INC (CARM) reported $44.7M in net income in Q3 2025. This represents an increase of 452.0% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what CARISMA THERAPEUTICS INC (CARM) reported on that line in every period on record.